These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


185 related items for PubMed ID: 16110039

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Chronic lymphocytic leukemia masquerading as uveitis.
    Gupta G, Larson RA, Jampol LM.
    Retina; 2007; 27(9):1311-2. PubMed ID: 18046244
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Advances in the diagnosis and treatment of chronic lymphocytic leukemia.
    Abbott BL.
    Clin Adv Hematol Oncol; 2004 Jul; 2(7):448-54. PubMed ID: 16163221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Fludarabine as a second-line treatment of advanced stage chronic lymphocytic leukemia.
    Ayyildiz O, Isikdogan A, Bolaman Z, Muftuoglu E.
    Saudi Med J; 2004 Dec; 25(12):2054-6. PubMed ID: 15711709
    [No Abstract] [Full Text] [Related]

  • 11. Direct antiglobulin test negative autoimmune haemolytic anaemia associated with fludarabine/cyclophosphamide/rituximab therapy.
    Garratty G, Petz LD.
    Br J Haematol; 2007 Nov; 139(4):622-3. PubMed ID: 17979948
    [No Abstract] [Full Text] [Related]

  • 12. [Specific palatal infiltration in B-cell chronic lymphocytic leukemia].
    Cervigón I, Palomo A, Torres-Iglesias LM, Solano F, Zapata AM.
    Actas Dermosifiliogr; 2011 May; 102(4):305-7. PubMed ID: 21354544
    [No Abstract] [Full Text] [Related]

  • 13. Progressive multifocal leukencephalopathy and cerebral toxoplasmosis in a patient with CLL.
    Desmond R, Lynch K, Gleeson M, Farrell M, Murphy P.
    Am J Hematol; 2010 Aug; 85(8):607. PubMed ID: 20029990
    [No Abstract] [Full Text] [Related]

  • 14. R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia.
    Tonino SH, van Gelder M, Eldering E, van Oers MH, Kater AP.
    Leukemia; 2010 Mar; 24(3):652-4. PubMed ID: 19956201
    [No Abstract] [Full Text] [Related]

  • 15. Fludarabine-associated autoimmune hemolytic anemia occurring in B-cell chronic lymphocytic leukemia.
    Nishida H, Murase T, Ueno H, Park JW, Yano T, Ikeda Y.
    Leuk Res; 2006 Dec; 30(12):1589-90. PubMed ID: 16542723
    [Abstract] [Full Text] [Related]

  • 16. Chronic lymphocytic leukemia in the next decade: where do we go from here?
    Keating MJ.
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):27-33. PubMed ID: 9685177
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical challenges in chronic lymphocytic leukemia.
    O'Brien S.
    Semin Hematol; 1998 Jul; 35(3 Suppl 3):22-6. PubMed ID: 9685176
    [No Abstract] [Full Text] [Related]

  • 19. [Successful combined treatment with rituximab and high dose immunoglobulin in a patient with chronic lymphocytic leukemia with fludarabine-induced severe immune thrombocytopenia].
    Telek B, Batár P, Uvardy M.
    Orv Hetil; 2005 Aug 21; 146(34):1791-3. PubMed ID: 16184881
    [Abstract] [Full Text] [Related]

  • 20. Monoclonal antibodies in chronic lymphocytic leukemia.
    Ferrajoli A, Faderl S, Keating MJ.
    Expert Rev Anticancer Ther; 2006 Sep 21; 6(9):1231-8. PubMed ID: 17020457
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.